Cargando…

Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy

PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes w...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyran, Marguerite, Tallet, Agnes, Resbeut, Michel, Ferre, Marjorie, Favrel, Veronique, Fau, Pierre, Moureau‐Zabotto, Laurence, Darreon, Julien, Gonzague, Laurence, Benkemouche, Ahcene, Varela‐Cagetti, Leonel, Salem, Naji, Farnault, Bertrand, Acquaviva, Marie‐Aimee, Mailleux, Hugues
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123145/
https://www.ncbi.nlm.nih.gov/pubmed/29959819
http://dx.doi.org/10.1002/acm2.12398
_version_ 1783352798752014336
author Tyran, Marguerite
Tallet, Agnes
Resbeut, Michel
Ferre, Marjorie
Favrel, Veronique
Fau, Pierre
Moureau‐Zabotto, Laurence
Darreon, Julien
Gonzague, Laurence
Benkemouche, Ahcene
Varela‐Cagetti, Leonel
Salem, Naji
Farnault, Bertrand
Acquaviva, Marie‐Aimee
Mailleux, Hugues
author_facet Tyran, Marguerite
Tallet, Agnes
Resbeut, Michel
Ferre, Marjorie
Favrel, Veronique
Fau, Pierre
Moureau‐Zabotto, Laurence
Darreon, Julien
Gonzague, Laurence
Benkemouche, Ahcene
Varela‐Cagetti, Leonel
Salem, Naji
Farnault, Bertrand
Acquaviva, Marie‐Aimee
Mailleux, Hugues
author_sort Tyran, Marguerite
collection PubMed
description PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes within 25 fractions. The planning process used a virtual bolus for the first optimization, then the monitors units were reoptimized without bolus, after fixing the segments shapes. Structures and treatment planning were exported on a second scanner (CT) performed during treatment as a consequence to modifications in patient's anatomy. The comparative end‐point was clinical target volume's coverage. The first analysis compared the VMAT plans made using the virtual bolus method (VB‐VMAT) to the plans without using it (NoVB‐VMAT) on the first simulation CT. Then, the same analysis was performed on the second CT. Finally, the level of degradation of target volume coverage between the two CT using VB‐VMAT was compared to results using a standard technique of forward‐planned multisegment technique (Tan‐IMRT). RESULTS: Using a virtual bolus for VMAT does not degrade dosimetric results on the first CT. No significant result in favor of the NoVB‐VMAT plans was noted. The VB‐VMAT method led to significant better dose distribution on a second CT with modified anatomies compared to NoVB‐VMAT. The clinical target volume's coverage by 95% (V95%) of the prescribed dose was 98.9% [96.1–99.6] on the second CT for VB‐VMAT compared to 92.6% [85.2–97.7] for NoVB‐VMAT (P = 0.0002). The degradation of the target volume coverage for VB‐VMAT is not worse than for Tan‐IMRT: the median differential of V95% between the two CT was 0.9% for VMAT and 0.7% for Tan‐IMRT (P = 1). CONCLUSION: This study confirms the safety and benefit of using a virtual bolus during the VMAT planning process to compensate potential breast shape modifications.
format Online
Article
Text
id pubmed-6123145
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61231452018-09-10 Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy Tyran, Marguerite Tallet, Agnes Resbeut, Michel Ferre, Marjorie Favrel, Veronique Fau, Pierre Moureau‐Zabotto, Laurence Darreon, Julien Gonzague, Laurence Benkemouche, Ahcene Varela‐Cagetti, Leonel Salem, Naji Farnault, Bertrand Acquaviva, Marie‐Aimee Mailleux, Hugues J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: This study evaluates the benefit of a virtual bolus method for volumetric modulated arc therapy (VMAT) plan optimization to compensate breast modifications that may occur during breast treatment. METHODS: Ten files were replanned with VMAT giving 50 Gy to the breast and 47 Gy to the nodes within 25 fractions. The planning process used a virtual bolus for the first optimization, then the monitors units were reoptimized without bolus, after fixing the segments shapes. Structures and treatment planning were exported on a second scanner (CT) performed during treatment as a consequence to modifications in patient's anatomy. The comparative end‐point was clinical target volume's coverage. The first analysis compared the VMAT plans made using the virtual bolus method (VB‐VMAT) to the plans without using it (NoVB‐VMAT) on the first simulation CT. Then, the same analysis was performed on the second CT. Finally, the level of degradation of target volume coverage between the two CT using VB‐VMAT was compared to results using a standard technique of forward‐planned multisegment technique (Tan‐IMRT). RESULTS: Using a virtual bolus for VMAT does not degrade dosimetric results on the first CT. No significant result in favor of the NoVB‐VMAT plans was noted. The VB‐VMAT method led to significant better dose distribution on a second CT with modified anatomies compared to NoVB‐VMAT. The clinical target volume's coverage by 95% (V95%) of the prescribed dose was 98.9% [96.1–99.6] on the second CT for VB‐VMAT compared to 92.6% [85.2–97.7] for NoVB‐VMAT (P = 0.0002). The degradation of the target volume coverage for VB‐VMAT is not worse than for Tan‐IMRT: the median differential of V95% between the two CT was 0.9% for VMAT and 0.7% for Tan‐IMRT (P = 1). CONCLUSION: This study confirms the safety and benefit of using a virtual bolus during the VMAT planning process to compensate potential breast shape modifications. John Wiley and Sons Inc. 2018-06-30 /pmc/articles/PMC6123145/ /pubmed/29959819 http://dx.doi.org/10.1002/acm2.12398 Text en © 2018 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Tyran, Marguerite
Tallet, Agnes
Resbeut, Michel
Ferre, Marjorie
Favrel, Veronique
Fau, Pierre
Moureau‐Zabotto, Laurence
Darreon, Julien
Gonzague, Laurence
Benkemouche, Ahcene
Varela‐Cagetti, Leonel
Salem, Naji
Farnault, Bertrand
Acquaviva, Marie‐Aimee
Mailleux, Hugues
Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title_full Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title_fullStr Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title_full_unstemmed Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title_short Safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
title_sort safety and benefit of using a virtual bolus during treatment planning for breast cancer treated with arc therapy
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123145/
https://www.ncbi.nlm.nih.gov/pubmed/29959819
http://dx.doi.org/10.1002/acm2.12398
work_keys_str_mv AT tyranmarguerite safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT talletagnes safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT resbeutmichel safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT ferremarjorie safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT favrelveronique safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT faupierre safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT moureauzabottolaurence safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT darreonjulien safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT gonzaguelaurence safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT benkemoucheahcene safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT varelacagettileonel safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT salemnaji safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT farnaultbertrand safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT acquavivamarieaimee safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy
AT mailleuxhugues safetyandbenefitofusingavirtualbolusduringtreatmentplanningforbreastcancertreatedwitharctherapy